#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphatic malformation Oesophageal achalasia Acquired ATTR amyloidosis Mitochondrial encephalomyopathy Vulval cancer recurrent Antisynthetase syndrome Pyoderma gangrenosum Haemophilia B with anti factor IX Chronic myeloid leukaemia Neuroendocrine carcinoma metastatic Endometrial cancer Anal cancer recurrent Ewing's sarcoma recurrent Systemic lupus erythematosus Dupuytren's contracture More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Basic Information Chondrosarcoma metastatic – Life with Disease MELAS syndrome – Treatment Idiopathic pulmonary fibrosis Testicular leiomyosarcoma – Treatment Prader-Willi syndrome – Diagnostics Short-bowel syndrome Uterine leiomyosarcoma – Basic Information Gastrointestinal stromal tumour – Basic Information Andersen-Tawil syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brimonidine Tartrate HYDROXYCHLOROQUINE Zoledronic Acid Monohydrate Xp-Dc+Tl+Klh Abc-31-116 Calcifediol Mbs2320 Ucp2 Lactose NVG-2089 Imipenem Monohydrate Gs-4182 Romiplostim TETRODOTOXIN GRNA-001 Pyruvic Acid Eprosartan Mesilate Olmesartan Medoxomil Fluorescein Sodium Tremelimumab More therapies…

    Learn about Your Condition

    Breast cancer in situ Retinal neovascularisation Endometrial cancer stage I Glomerulonephritis Amyotrophic lateral sclerosis Low cardiac output syndrome Ophthalmoplegia Pelizaeus-Merzbacher disease Acute respiratory failure C3 glomerulopathy Pulmonary resection Chronic myeloid leukaemia Arterial disorder Limb reduction defect Paraganglion neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Istituto Oncologico Veneto

Istituto Oncologico Veneto

Via Gattamelata 64, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Volrustomig with FOLFIRI and Bevacizumab for Colorectal Cancer Patients Without Liver Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Fluorouracil
    France Germany Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Abemaciclib
    • Fulvestrant
    • Leuprorelin Acetate
    Austria Belgium France Germany Italy The Netherlands +3

  • Study of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Adagrasib
    • Carboplatin
    • Cisplatin
    Austria Belgium Bulgaria Croatia France Germany +9

  • Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alectinib Hydrochloride
    • Nvl-655
    Austria Belgium Czechia Denmark France Germany +7

  • Study Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive gastric cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Capecitabine
    • Cisplatin
    Austria Belgium France Germany Hungary Italy +3

  • Study of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive biliary tract cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Cisplatin
    • Durvalumab
    Austria Belgium Czechia France Germany Italy +4

  • Study Comparing Rinatabart Sesutecan with Other Treatments for Patients with Platinum-Resistant Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Topotecan
    • Doxorubicin Hydrochloride
    • Gemcitabine Hydrochloride
    Austria Belgium Czechia Denmark France Germany +6

  • Study on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • GSK5733584
    • Bevacizumab
    • Dostarlimab
    Belgium Denmark Finland France Germany Greece +6

  • Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Capecitabine
    • Cisplatin
    Austria Belgium Czechia France Germany Italy +6

  • Study of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • Ifinatamab Deruxtecan
    Czechia France Germany Italy Norway
Previous Page
1 … 6 7 8 9 10 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!